KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells

Development of chemoresistance remains a major hurdle for triple negative breast cancer treatment. Previous studies suggest that CD44+/CD24- cells, subpopulation of cancer stem cells with self-renewing and tumor-initiating capacities, are partly responsible for chemoresistance and therapeutic failur...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Meng, Zhuang, Huiru, Xia, Rui, Gan, Lei, Wu, Yuantao, Ma, Junzhe, Sun, Yihui, Zhuang, Zhixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696167/
https://www.ncbi.nlm.nih.gov/pubmed/29190901
http://dx.doi.org/10.18632/oncotarget.20785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696167/
https://www.ncbi.nlm.nih.gov/pubmed/29190901
http://dx.doi.org/10.18632/oncotarget.20785

Ejemplares similares